Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Join Medicilon at the 2022 NESACS Annual Advances in Chemical Sciences Symposium meeting

Page View:

2022 NESACS Annual Advances in Chemical Sciences Symposium meeting.jpgWe are very pleased to announce that Medicilon will participate in the Tenth Annual Advances in Chemical Sciences Symposium. It kicks off on October 7, 2022 in Waltham, the Medicilon American team will be present throughout the event at Booth #15. We sincerely invite you to come to have a discussion with us!

About Tenth Annual Advances in Chemical Sciences Symposium

The Northeastern Section of the ACS was founded on May 26, 1926, with the mission of advancing chemistry and chemical engineering, promoting research, improving the qualifications of members through high standards of education and professional ethics, increasing and disseminating knowledge of chemistry, and promoting scientific interest and inquiry. The Tenth Annual Advances in Chemical Sciences Symposium will begin in Waltham on 7 October 2022.The one-day workshop focused on medicinal chemistry, organic synthesis and methodology and was attended by prominent scientists from industry and academia.

About Medicilon

Medicilon is an integrated contract research organization (CRO), providing comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. We provide one-stop customized R&D solutions ranging from precise drug targeting to IND filing assistance. Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D.

 Medicilon Medicinal Chemistry Services

At Medicilon, Our medicinal chemistry team is capable of flexibly applying computer chemistry to assist compound design process. In the meantime, we apply advanced drug discovery technologies, including proteolysis-targeting chimera (PROTAC), DNA-encoded chemical library (DEL) and antibody drug conjugation (ADC). We are also proud of our rich experience in innovative design and patent strategies that complement our technologies. In addition, our responsive project management and effective communication help optimize our project delivery.

Medicilon Synthetic Chemistry

Medicilon is proud of our extensive expertise in synthetic organic chemistry. With a team of over 1200 chemists, our synthetic chemistry department is capable of the independent design of synthesis pathways and complex compound treatments, key to helping accelerate our clients' drug discovery. As we pay great attention to scientific morality, we protect our clients' intellectual property rights tirelessly and guarantee data integrity. Furthermore, our projects are always undertaken with a fundamental focus on safety and green chemistry.



❖ AI supported route design and process optimization

❖ Synthesis of high-quality compounds from milligram to kilogram

❖ Scaling up Compound Production to Non-GMP Level

❖ Custom chemical synthesis

❖ Scale up

Relevant newsRelevant news